$6.47
0.00%
Nasdaq, Aug 08, 03:30 pm CET
ISIN
AGP8696W1045
Symbol
SVA

Sinovac Biotech Ltd. Stock price

$6.47
+0.00 0.00% 1M
+0.00 0.00% 6M
+0.00 0.00% YTD
+0.00 0.00% 1Y
+0.00 0.00% 3Y
+0.00 0.00% 5Y
+1.15 21.62% 10Y
+3.79 141.42% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.00 0.00%
ISIN
AGP8696W1045
Symbol
SVA
Industry

Key metrics

Basic
Market capitalization
$639.9m
Enterprise Value
$-9.6b
Net debt
positive
Cash
$10.6b
Shares outstanding
99.6m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.5 | -
EV/Sales
negative | -
EV/FCF
23.8
P/B
0.1
Financial Health
Equity Ratio
63.8%
Return on Equity
-1.2%
ROCE
-3.0%
ROIC
-45.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$429.2m | -
EBITDA
$-231.9m | -
EBIT
$-362.0m | -
Net Income
$-130.7m | -
Free Cash Flow
$-404.7m
Growth (TTM | estimate)
Revenue
2.2% | -
EBITDA
82.8% | -
EBIT
76.0% | -
Net Income
63.7% | -
Free Cash Flow
-84.0%
Margin (TTM | estimate)
Gross
92.1%
EBITDA
-54.0% | -
EBIT
-84.3%
Net
-30.5% | -
Free Cash Flow
-94.3%
More
EPS
$-1.3
FCF per Share
$-4.1
Short interest
0.3%
Employees
-
Rev per Employee
-
Show more

Is Sinovac Biotech Ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Financial data from Sinovac Biotech Ltd.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
429 429
2% 2%
100%
- Direct Costs 34 34
95% 95%
8%
395 395
300% 300%
92%
- Selling and Administrative Expenses 443 443
51% 51%
103%
- Research and Development Expense 337 337
17% 17%
79%
-232 -232
83% 83%
-54%
- Depreciation and Amortization 130 130
20% 20%
30%
EBIT (Operating Income) EBIT -362 -362
76% 76%
-84%
Net Profit -131 -131
64% 64%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Sinovac Biotech Ltd. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sinovac Biotech Ltd. Stock News

Neutral
Business Wire
about one month ago
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”) today issued the following update to set the record straight regarding the Special Meeting of Shareholders (the “Special Meeting”): The Special Meeting was validly adjourned by SINOVAC Chairman Chiang Li on July 8, 2025, due to pending litigation in Antigua regarding the validity ...
Neutral
Business Wire
about one month ago
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Mr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan and Mr. Yin Weidong (col...
Neutral
Business Wire
about one month ago
BEIJING--(BUSINESS WIRE)--The Board of Directors of SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading biopharmaceutical company in China, categorically rejects the recent deceptive and illegal claims by SAIF and the Imposter Former Board that it purported to “reconvene” the adjourned Special Meeting of Shareholders (the “Special Meeting”) and announced sham voting resul...
More Sinovac Biotech Ltd. News

Company Profile

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Head office Antigua and Barbuda
CEO Wei Yin
Founded 1993
Website www.sinovac.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today